Foa Trastu

Trastuzumab Deruxtecan for Breast Cancer | NEJM 2:06
Trastuzumab Deruxtecan for Breast Cancer | NEJM NEJM Group 24,013 2 года назад
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer 3:50
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer Oncology Associates 37,446 8 лет назад
Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms 30:57
Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms Total Health | Oncology 3,010 3 года назад
APT: adjuvant paclitaxel and trastuzumab for node-negative, HER2+ breast cancer 1:56
APT: adjuvant paclitaxel and trastuzumab for node-negative, HER2+ breast cancer VJOncology 3,677 1 год назад
Trastuzumab (Herceptin) and Pertuzumab (Perjeta) for Breast Cancer: What You Need to Know 8:31
Trastuzumab (Herceptin) and Pertuzumab (Perjeta) for Breast Cancer: What You Need to Know Yerbba – Breast Cancer 1,689 13 дней назад
Trastuzumab deruxtecan: a promising agent for treating HER2-low breast cancer? 4:01
Trastuzumab deruxtecan: a promising agent for treating HER2-low breast cancer? VJOncology 1,486 3 года назад
Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2- Positive Metastatic Breast Cancer 4:31
Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2- Positive Metastatic Breast Cancer Dana-Farber Cancer Institute 3,029 4 года назад
HER2CLIMB-05: tucatinib + trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic BC 1:47
HER2CLIMB-05: tucatinib + trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic BC VJOncology 311 1 год назад
CLEOPATRA: pertuzumab, trastuzumab & chemo for HER2+ mBC 2:40
CLEOPATRA: pertuzumab, trastuzumab & chemo for HER2+ mBC VJOncology 3,272 4 года назад
Trastuzumab Deruxtecan for Patients w/ HER2-Positive Advanced Gastric or GE Junction Adenocarcinoma 6:45
Trastuzumab Deruxtecan for Patients w/ HER2-Positive Advanced Gastric or GE Junction Adenocarcinoma PracticeUpdate 90 3 года назад
Updated analysis from MOUNTAINEER: tucatinib and trastuzumab for HER2-positive mCRC 1:14
Updated analysis from MOUNTAINEER: tucatinib and trastuzumab for HER2-positive mCRC VJOncology 114 1 год назад
Remarkable data: trastuzumab deruxtecan for HER2+ BC 2:37
Remarkable data: trastuzumab deruxtecan for HER2+ BC VJOncology 136 4 года назад
TUXEDO-1: trastuzumab deruxtecan for the treatment of HER2-positive breast cancer brain metastases 1:29
TUXEDO-1: trastuzumab deruxtecan for the treatment of HER2-positive breast cancer brain metastases VJOncology 525 2 года назад
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer 5:46
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer ecancer 2,565 4 года назад
Trastuzumab Deruxtecan for the Treatment of HER2+ Breast Cancer 5:59
Trastuzumab Deruxtecan for the Treatment of HER2+ Breast Cancer Targeted Oncology 3,029 4 года назад
PFS Data Support Approval of Fam-Trastuzumab Deruxtecan-nxki for HER2+ Breast Cancer 1:39
PFS Data Support Approval of Fam-Trastuzumab Deruxtecan-nxki for HER2+ Breast Cancer Targeted Oncology 165 4 года назад
HER2CLIMB-04: tucatinib + trastuzumab deruxtecan in HER2+ breast cancer 1:12
HER2CLIMB-04: tucatinib + trastuzumab deruxtecan in HER2+ breast cancer VJOncology 171 3 года назад
Research Update for HER2-Positive MBC | 2021-2022 EMBRACE MBC Virtual Forum Series 56:42
Research Update for HER2-Positive MBC | 2021-2022 EMBRACE MBC Virtual Forum Series Dana-Farber Cancer Institute 2,236 2 года назад
Susan Desmond-Hellmann (UCSF): Herceptin and Drug Development 12:44
Susan Desmond-Hellmann (UCSF): Herceptin and Drug Development iBiology Science Stories 8,928 13 лет назад

Сейчас ищут